Old Republic International Corporation, through its subsidiaries, provides insurance underwriting and related services primarily in the United States and Canada. The company operates in two segments, Specialty Insurance and Title Insurance. The Specialty Insurance segment offers accident and health, aviation, commercial auto, commercial multi-peril, commercial property, excess and surplus, general liability, home and auto warranty, inland marine, travel accident, and workers' compensation insurance products; and financial indemnity products for specialty coverages, including errors and omissions, fidelity, directors and officers, and surety. This segment provides its insurance products to businesses, state and local governments, and other institutions in transportation, commercial construction, healthcare, education, retail and wholesale trade, forest products, energy, general manufacturing, and financial services industries. The Title Insurance segment offers lenders' and owners' policies to real estate purchasers and investors based upon searches of the public records. This segment also provides escrow closing and construction disbursement services; and real estate information products, national default management services, and various other services pertaining to real estate transfers and loan transactions. Old Republic International Corporation was founded in 1923 and is based in Chicago, Illinois.

Old Republic International Corporation

Orica Limited ( ($AU:ORI) ) just unveiled an announcement. Orica Limited has announced a change in the director’s interest, with Vikas Bansal acqui...

Orica Limited Announces Director’s Acquisition of Shares

Oric Pharmaceuticals Inc (ORIC) has disclosed a new risk, in the Employment / Personnel category. Oric Pharmaceuticals Inc.’s strategic pipeline pr...

Oric Pharmaceuticals’ 2025 Restructuring: Potential Risks and Financial Implications

J.P. Morgan analyst Lee Power maintained a Buy rating on Orica Limited on November 13 and set a price target of A$26.00. The company’s shares close...

J.P. Morgan Sticks to Its Buy Rating for Orica Limited (OCLDF)

Wedbush analyst David Nierengarten maintained a Buy rating on Oric Pharmaceuticals today and set a price target of $20.00. Nierengarten covers the ...

Wedbush Sticks to Its Buy Rating for Oric Pharmaceuticals (ORIC)

Morgans analyst Belinda Moore maintained a Buy rating on Orica Limited today and set a price target of A$28.00. According to TipRanks, Moore is a 4...

Morgans Remains a Buy on Orica Limited (OCLDF)

The latest announcement is out from Oric Pharmaceuticals ( ($ORIC) ). Oric Pharmaceuticals announced an update on their ORIC-944 clinical trials, h...

Oric Pharmaceuticals Reports Promising ORIC-944 Trial Results

Citi analyst William Park CPA maintained a Buy rating on Orica Limited today and set a price target of A$24.05. Park CPA covers the Industrials sec...

Orica Limited (OCLDF) Gets a Buy from Citi

An update from Orica Limited ( ($AU:ORI) ) is now available. Orica Limited has released its corporate governance statement for the financial year e...

Orica Limited Releases 2025 Corporate Governance Statement

The latest update is out from Orica Limited ( ($AU:ORI) ). Orica Limited has released its Corporate Governance Statement for the year ending Septem...

Orica Limited Upholds Strong Corporate Governance and Ethical Standards

The latest update is out from Orica Limited ( ($AU:ORI) ). Orica Limited reported a strong financial performance for the year ending September 2025...

Orica Limited Reports Strong Financial Performance for FY 2025

Octopus Renewables Infrastructure Trust Plc ( ($GB:ORIT) ) has issued an announcement. Octopus Renewables Infrastructure Trust (ORIT) has assessed ...

ORIT Evaluates Impact of Proposed UK Government Changes to Renewable Schemes

In a report released today, Gregory Peters from Raymond James reiterated a Buy rating on Old Republic International, with a price target of $47.00....

Old Republic International (ORI) Gets a Buy from Raymond James

In a report released today, Paul Newsome from Piper Sandler maintained a Buy rating on Old Republic International, with a price target of $46.00. T...

Piper Sandler Keeps Their Buy Rating on Old Republic International (ORI)

RBC Capital analyst Mark Wilson CFA maintained a Buy rating on Orica Limited yesterday and set a price target of A$24.70. The company’s shares clos...

RBC Capital Sticks to Its Buy Rating for Orica Limited (OCLDF)

In a report released today, Nathan Reilly from UBS maintained a Buy rating on Orica Limited, with a price target of A$25.00. The company’s shares c...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ORI	$46.21	+2.51%	1.03M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ORI	$46.21	+2.5%	1.03M
3
4
5
6

ORI

ORI

No Data Available

Get Old Republic International Corporation Data in Excel

Get Old Republic International Corporation Data in Excel